Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Masitinib mesylate application for conditional approval
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Delayed visual evoked response in optic neuritis.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Episode 17 with Dr. Hans Lassmann on the usefulness of animal models for studying multiple sclerosis.
Episode 18 with Dr. Samuel Ludwin on new approaches to remyelination therapies.
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Episode 10 with Dr. Richard Ransohoff on his group's latest research
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
The force awakens: insights into the origin and formation of microglia.
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.

Pages